Artacent VeriClen is a single use, dehydrated, sterilized, human amnion-chorion membrane allograft It is an allogeneic matrix cellular and tissue-based skin substitute for wound healing.
INTENDED USES: Artacent VeriClen is intended for use as a wound covering for acute and chronic wounds (Diabetic Foot Ulcers, Pressure Ulcers, Venous Stasis Ulcers, Burns)
CLAIMED BENEFITS: Artacent VeriClen is regulated as a human cell, tissue, or cellular or tissue-based product. Full thickness amniotic tissue graft sterilized via e-beam.
An invitation to view this topic will be emailed to specified recipients.
Sorry, this content is only available to registered members. Please register for FREE account to gain access.
To access this premium feature and more, upgrade to a premium plan today. Or browse to enjoy free content and tools.
WoundReference is a clinical decision support platform for experienced and new wound care clinicians at the point-of-care